Sort
85,873 grants matching “alzheimers”
NRT-UtB: Neurophotonics
$2,928,842Thomas G Bifano · Trustees Of Boston University · · FY2016 · EDU
Main Administrative Core
$2,927,614Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2023 · AG
Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD Cohort
$2,927,138Marilyn S Albert · Johns Hopkins University · U19 · FY2015 · AG
A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients
$2,926,978Hans Joerg Moebius · Athira Pharma, Inc. · R01 · FY2022 · AG
Emory Alzheimer's Disease Research Center
$2,925,599Allan I Levey · Emory University · P30 · FY2022 · AG
Characterizing WDR23 in Alzheimer's disease pathology
$2,924,025Sean P. Curran · University Of Southern California · RF1 · FY2019 · AG
Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD Cohort
$2,923,791Marilyn S Albert · Johns Hopkins University · U19 · FY2018 · AG
Biological heterogeneity in ADRD
$2,923,529Thomas J. Grabowski · University Of Washington · P30 · FY2023 · AG
Alzheimer's Disease Research Center
$2,922,029Douglas R Galasko · University Of California, San Diego · P50 · FY2012 · AG
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
$2,920,663Olga V Fedorova · National Institute On Aging · ZIA · FY2017 · AG
Perimenopause in Brain Aging and Alzheimer's Disease
$2,919,843Roberta Diaz Brinton · University Of Arizona · P01 · FY2025 · AG
UCSD Alzheimer's Disease Research Center P50
$2,919,722Douglas R Galasko · University Of California, San Diego · P50 · FY2015 · AG
Cerebral tau deposition and comorbid cerebrovascular disease across the Alzheimer's disease continuum in Mexican Americans
$2,919,399Mohamad Habes · University Of Texas Hlth Science Center · R01 · FY2024 · AG
Clinical and biomarker studies in Alzheimer's disease and related disorders
$2,919,364Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2021 · AG
Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease
$2,918,576Hong-Wei Dong · University Of California Los Angeles · U01 · FY2024 · AG
MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS
$2,917,850Neelum T Aggarwal · Rush University Medical Center · R01 · FY2025 · AG
Duke/UNC Alzheimer's Disease Research Center
$2,917,585Heather E. Whitson · Duke University · P30 · FY2023 · AG
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,916,751Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Alzheimer's Disease Research Center
$2,916,244Douglas R Galasko · University Of California, San Diego · P50 · FY2009 · AG
Modulation Of Neuronal Channels and Receptors in the Brain
$2,915,682Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Biological heterogeneity in ADRD
$2,913,613Thomas J. Grabowski · University Of Washington · P30 · FY2024 · AG
Pilot Studies Core
$2,910,851Abraham Aizer Brody · Brown University · U54 · FY2022 · AG
PREVENTABLE Data Coordinating Center
$2,910,475Bradley G Hammill · Duke University · U19 · FY2024 · AG
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
$2,910,321Olga V Fedorova · National Institute On Aging · ZIA · FY2019 · AG
The Alzheimer Disease Sequence Analysis Collaborative
$2,909,935Jonathan L. Haines · Case Western Reserve University · U01 · FY2020 · AG